INIFY Laboratories (INIFY.OL) Stock Price

INIFY Laboratories Price

CLOSED
8.06SEK+0.92 (+12.14 %)
Market closed

Revenue has compounded at 329.5% per year over the past 2 years to 21.69 M SEK. INIFY Laboratories's net margin stands at -308.5%, up from -4,469.8% several years earlier. The stock trades about 150% above its 52-week low.

INIFY Laboratories stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of INIFY Laboratories over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how INIFY Laboratories stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing INIFY Laboratories's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

INIFY Laboratories Stock Price History
DateINIFY Laboratories Price
8/17/20268.06 SEK
8/14/20267.14 SEK
8/13/20266.46 SEK
8/12/20266.49 SEK
8/11/20267.54 SEK
8/10/20267.94 SEK
8/7/20267.92 SEK
8/6/20267.94 SEK
8/5/20268.16 SEK
8/4/20268.02 SEK
7/31/20268.04 SEK
7/30/20268.22 SEK
7/29/20268.22 SEK
7/28/20268.30 SEK
7/27/20268.30 SEK
7/24/20268.12 SEK
7/23/20267.98 SEK
7/22/20267.95 SEK
7/21/20267.91 SEK
7/20/20268.01 SEK
7/17/20267.98 SEK
7/16/20267.98 SEK
7/15/20267.98 SEK
7/14/20267.92 SEK
7/13/20267.82 SEK
7/10/20267.84 SEK
7/9/20267.75 SEK
7/8/20267.75 SEK
7/7/20267.70 SEK
7/6/20267.75 SEK
7/3/20267.75 SEK
7/2/20267.69 SEK
7/1/20266.85 SEK
6/30/20267.53 SEK
6/29/20267.54 SEK
6/26/20267.83 SEK
6/25/20267.75 SEK
6/24/20267.94 SEK
6/23/20267.31 SEK
6/22/20267.41 SEK
6/19/20267.91 SEK
6/18/20267.91 SEK
6/17/20267.41 SEK
6/16/20267.91 SEK
6/15/20267.91 SEK
6/12/20267.91 SEK
6/11/20266.67 SEK
6/10/20266.43 SEK
6/9/20266.43 SEK
6/8/20265.09 SEK
6/5/20265.19 SEK
6/4/20264.99 SEK
6/3/20265.04 SEK
6/2/20265.09 SEK
6/1/20265.14 SEK
5/29/20264.90 SEK
5/28/20264.82 SEK
5/27/20264.15 SEK
5/26/20263.66 SEK
5/22/20263.58 SEK
5/21/20263.87 SEK
5/20/20263.84 SEK
5/19/20263.87 SEK
5/18/20263.89 SEK
5/15/20263.91 SEK
5/13/20263.91 SEK
5/12/20263.93 SEK
5/11/20263.93 SEK
5/8/20263.93 SEK
5/7/20263.56 SEK
5/6/20263.46 SEK
5/5/20263.46 SEK
5/4/20263.56 SEK
4/30/20263.56 SEK
4/29/20263.93 SEK
4/28/20264.03 SEK
4/27/20263.95 SEK
4/24/20263.91 SEK
4/23/20263.50 SEK
4/22/20263.50 SEK
4/21/20263.52 SEK
4/20/20263.48 SEK
4/17/20264.05 SEK
4/16/20263.60 SEK
4/15/20263.84 SEK
4/14/20263.48 SEK
4/13/20263.48 SEK
4/10/20263.93 SEK
4/9/20263.91 SEK
4/8/20263.91 SEK
4/7/20263.93 SEK
4/1/20263.60 SEK
3/31/20264.05 SEK
3/30/20264.63 SEK
3/27/20264.63 SEK
3/26/20264.63 SEK
3/25/20264.63 SEK
3/24/20264.63 SEK
3/23/20264.63 SEK
3/20/20264.63 SEK
3/19/20264.63 SEK
3/18/20264.63 SEK
3/17/20264.63 SEK
3/16/20264.45 SEK
3/13/20264.82 SEK
3/12/20264.82 SEK
3/11/20264.05 SEK
3/10/20263.86 SEK
3/9/20263.86 SEK
3/6/20263.86 SEK
3/5/20263.95 SEK
3/4/20263.95 SEK
3/3/20263.95 SEK
3/2/20263.95 SEK
2/27/20263.95 SEK
2/26/20263.95 SEK
2/25/20263.56 SEK
2/24/20263.56 SEK
2/23/20264.05 SEK
2/20/20264.11 SEK
2/19/20263.86 SEK
2/18/20263.56 SEK
2/17/20263.56 SEK
2/16/20263.58 SEK
2/13/20263.58 SEK
2/12/20263.58 SEK
2/11/20263.50 SEK
2/10/20263.50 SEK
2/9/20263.50 SEK
2/6/20263.82 SEK
2/5/20264.15 SEK
2/4/20263.68 SEK
2/3/20263.93 SEK
2/2/20263.93 SEK
1/30/20263.72 SEK
1/29/20263.76 SEK
1/28/20263.72 SEK
1/27/20263.54 SEK
1/26/20263.54 SEK
1/23/20263.46 SEK
1/22/20263.32 SEK
1/21/20263.56 SEK
1/20/20263.56 SEK
1/19/20263.56 SEK
1/16/20263.84 SEK
1/15/20263.76 SEK
1/14/20263.48 SEK
1/13/20263.95 SEK
1/12/20264.13 SEK
1/9/20264.17 SEK
1/8/20264.05 SEK
1/7/20263.46 SEK
1/6/20263.46 SEK
1/5/20263.46 SEK
1/2/20264.74 SEK
12/30/20254.78 SEK
12/29/20253.48 SEK
12/23/20253.46 SEK
12/22/20253.48 SEK
12/19/20253.48 SEK
12/18/20253.48 SEK
12/17/20253.76 SEK
12/16/20253.68 SEK
12/15/20253.34 SEK
12/12/20253.46 SEK
12/11/20253.30 SEK
12/10/20253.22 SEK
12/9/20253.66 SEK
12/8/20253.50 SEK
12/5/20253.64 SEK
12/4/20253.64 SEK
12/3/20253.82 SEK
12/2/20254.88 SEK
12/1/20254.88 SEK
11/28/20254.88 SEK
11/27/20254.45 SEK
11/26/20253.95 SEK
11/25/20253.93 SEK
11/24/20253.74 SEK
11/21/20253.56 SEK
11/20/20253.58 SEK
11/19/20253.56 SEK
11/18/20253.56 SEK
11/17/20253.76 SEK
11/14/20254.47 SEK
11/13/20254.47 SEK
11/12/20253.95 SEK
11/11/20255.44 SEK
11/10/20255.44 SEK
11/7/20255.44 SEK
11/6/20255.44 SEK
11/5/20255.04 SEK
11/4/20255.78 SEK
11/3/20255.78 SEK
10/31/20255.78 SEK
10/30/20255.14 SEK
10/29/20255.39 SEK
10/28/20255.54 SEK
10/27/20255.04 SEK
10/24/20255.24 SEK
10/23/20255.24 SEK
10/22/20256.23 SEK
10/21/20256.23 SEK
10/20/20256.08 SEK
10/17/20256.08 SEK
10/16/20256.08 SEK
10/15/20255.93 SEK
10/14/20255.63 SEK
10/13/20255.54 SEK
10/10/20255.54 SEK
10/9/20255.54 SEK
10/8/20255.24 SEK
10/7/20255.29 SEK
10/6/20255.88 SEK
10/3/20255.88 SEK
10/2/20255.34 SEK
10/1/20255.39 SEK
9/30/20255.39 SEK
9/29/20255.58 SEK
9/26/20255.29 SEK
9/25/20255.54 SEK
9/24/20255.34 SEK
9/23/20255.83 SEK
9/22/20255.88 SEK
9/19/20255.98 SEK
9/18/20255.19 SEK
9/17/20255.44 SEK
9/16/20255.44 SEK
9/15/20255.58 SEK
9/12/20255.78 SEK
9/11/20255.29 SEK
9/10/20255.39 SEK
9/9/20255.24 SEK
9/8/20255.24 SEK
9/5/20255.34 SEK
9/4/20255.98 SEK
9/3/20255.88 SEK
9/2/20255.04 SEK
9/1/20256.18 SEK
8/29/20255.09 SEK
8/28/20255.44 SEK
8/27/20254.94 SEK
8/26/20255.39 SEK
8/25/20255.39 SEK
8/22/20255.19 SEK
8/21/20255.04 SEK
8/20/20254.99 SEK
8/19/20255.54 SEK
Access this data via the Eulerpool API
Get Free API Key

INIFY Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
1.18 M SEK
-54.96 M SEK
-52.56 M SEK
Jan 1, 2024
12.94 M SEK
-52.23 M SEK
-50.91 M SEK
Jan 1, 2025
21.69 M SEK
-68.66 M SEK
-66.92 M SEK

INIFY Laboratories Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 19, 2026, 3:19 AM
 
REVENUEM SEK
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM SEK
EBITM SEK
EBIT MARGIN%
NET INCOMEM SEK
NET INCOME GROWTH%
SHARESM
202320242025
1.0012.0021.00
–1,100.0075.00
1,800.0091.6785.71
18.0011.0018.00
-54.00-52.00-68.00
-5,400.00-433.33-323.81
-52.00-50.00-66.00
–-3.8532.00
81.2181.2181.21
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales INIFY Laboratories generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue INIFY Laboratories retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare INIFY Laboratories's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares INIFY Laboratories has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against INIFY Laboratories's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

INIFY Laboratories stock margins

The INIFY Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of INIFY Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for INIFY Laboratories.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
71.42 %
-4,673.85 %
-4,469.82 %
Jan 1, 2024
85.68 %
-403.51 %
-393.29 %
Jan 1, 2025
84.54 %
-316.54 %
-308.49 %

INIFY Laboratories Stock Revenue, EBIT, Earnings per Share

The INIFY Laboratories earnings per share therefore indicates how much revenue INIFY Laboratories has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2023
0.00 SEK
0.00 SEK
0.00 SEK
Jan 1, 2024
0.00 SEK
0.00 SEK
0.00 SEK
Jan 1, 2025
0.00 SEK
0.00 SEK
0.00 SEK

INIFY Laboratories business model & stock analysis

INIFY Laboratories Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

INIFY Laboratories historical P/E ratio, EBIT multiple, and P/S ratio

INIFY Laboratories annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

INIFY Laboratories shares outstanding

The number of shares of INIFY Laboratories was 81.21 M in 2025. This indicates how many shares INIFY Laboratories is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2023
81.21 M Stocks
Jan 1, 2024
81.21 M Stocks
Jan 1, 2025
81.21 M Stocks
Price targets and forecasts for INIFY Laboratories are not yet available.

INIFY Laboratories shareholder structure

% Name
0.21742%
Ingvar (Martin)
Ingvar (Martin)
0.14387%
Sandén (Olof)
Sandén (Olof)
0.11212%
Palm (Fredrik)
Palm (Fredrik)
0.08989%
Linderoth (Ann-Charlotte)
Linderoth (Ann-Charlotte)

INIFY Laboratories Executives and Management Board

9 members · avg. age 65 · 33 % women

Management

FP

Mr. Fredrik Palm

Chief Executive Officer

–
AL

Ms. Ann-Charlotte Linderoth

Chief Financial Officer

–
AJ

Mr. Arto Jarvinen

Chief Technology Officer

–
EE

Ms. Emelie Edvigsson

Laboratory Manager

–
JK

Ms. Johanna Karling (60)

Chief Quality Officer

–

Board of Directors

LS

Mr. Lars Sanden (61)

Chairman of the Board · since 2021

–
MA

Mr. Magnus Aurell

Commercial Director

–
KI

Knut Ingvar (68)

Director

–
MJ

Mr. Magne Jordanger (70)

Director

–

Frequently asked questions about INIFY Laboratories

Converted at the current exchange rate, the INIFY Laboratories share trades at 0.73 EUR (8.06 SEK).

No history available for INIFY Laboratories.

The revenue cannot currently be calculated for INIFY Laboratories.

The profit cannot currently be calculated for INIFY Laboratories.

The P/E ratio cannot be calculated for INIFY Laboratories at the moment.

The P/S cannot be calculated for INIFY Laboratories currently.

The Eulerpool Quality Score for INIFY Laboratories is 2/10.

The ISIN of INIFY Laboratories is SE0017486103. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of INIFY Laboratories is A3DFA6. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of INIFY Laboratories is INIFY.OL. The ticker symbol is used to trade INIFY Laboratories shares on the stock exchange.

INIFY Laboratories paid dividends every year for the past 0 years.

INIFY Laboratories is assigned to the 'Health' sector.

The dividends of INIFY Laboratories are distributed in SEK.

All fundamentals and in-depth analysis of INIFY Laboratories

Our stock analysis for INIFY Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of INIFY Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

INIFY Laboratories Stock
INIFY Laboratories Revenue→
INIFY Laboratories Stock
INIFY Laboratories Net Income→
INIFY Laboratories Stock
INIFY Laboratories P/E→
INIFY Laboratories Stock
INIFY Laboratories P/S→
INIFY Laboratories Stock
INIFY Laboratories EBIT→
INIFY Laboratories Stock
INIFY Laboratories Dividend→
INIFY Laboratories Stock
INIFY Laboratories Directors Dealings→
INIFY Laboratories Stock
INIFY Laboratories Stocks→
INIFY Laboratories Stock
INIFY Laboratories Market capitalization→
INIFY Laboratories Stock
INIFY Laboratories Debt→
INIFY Laboratories Stock
INIFY Laboratories Liabilities→
INIFY Laboratories Stock
INIFY Laboratories Equity→
INIFY Laboratories Stock
INIFY Laboratories AAQS→
INIFY Laboratories Stock
INIFY Laboratories Employees→
INIFY Laboratories Stock
INIFY Laboratories ROE→
INIFY Laboratories Stock
INIFY Laboratories ROA→
INIFY Laboratories Stock
INIFY Laboratories ROCE→
INIFY Laboratories Stock
INIFY Laboratories News→
INIFY Laboratories Stock
INIFY Laboratories Analyst Price Targets→

Health Stocks

Initiator Pharma A/SInhibrx BiosciencesINKON Life Technology CoInhibitor TherapeuticsInMed PharmaceuticalsInhibikase TherapeuticsInmodeInhalation Sciences SwedenINmune BioIngen TechnologiesInnate PharmaInfuSystem HoldingsAll Stocks A–Z →